Abstract: A trim for a vehicle and a glass assembly are provided. The trim includes a trim body, a flexible light emitter, and a light-transmitting member. The trim body has an inner surface and an outer surface opposite to the inner surface, and the flexible light emitter is attached to the inner surface. The trim body defines multiple light-transmitting through holes, and the multiple light-transmitting through holes extend through the inner surface and the outer surface and form a light-emitting region on the outer surface of the trim body. The light-transmitting member is located between the trim body and the flexible light emitter and is configured to generate a light effect in the light-emitting region. The flexible light emitter is configured to generate light that exits through the light-transmitting member and the multiple light-transmitting through holes.

Abstract: Application of a composition of FBP and a blood concentration stabilizer thereof in manufacturing medicaments for preventing and treating metabolic diseases and metabolic dysfunction related diseases. The FBP may also be a pharmaceutically acceptable salt or hydrate of prototype thereof, a prodrug thereof, or a derivative thereof. The blood concentration stabilizer refers to a medicament or substance for treating diabetes capable of slowing down rapid in vivo degradation of FBP in a pharmaceutical preparation. The composition can cause a higher FBP blood concentration peak value and a more stable blood concentration, and can reduce an FBP dosage and thus can reduce the toxicity resulted from a large amount of inorganic phosphorus entering systemic circulation after degradation of a large dosage of FBP.

Abstract: The invention relates generally to novel antibiotics and their analogs, to processes for the preparation of these novel antibiotics, to pharmaceutical compositions comprising the novel antibiotics; and to methods of using the novel antibiotics to treat or inhibit various disorders.

Abstract: Processes for producing shikimic acid through extraction from sweetgum, pine and cedar plant tissues and the shikimic acid produced by such processes.

Abstract: Improved methods for producing shikimic acid and the use of sweetgum plant tissues in the production of shikimic acid.

Abstract: The use of camptothecin (CPT), hyperoside and/or trifolin in preventing or inhibiting the growth of fungal pathogens, including molds.